4/A: Casdin Partners Amends Form 4 Filing for BioLife Solutions Inc. (BLFS) Following PanThera CryoSolutions Acquisition

Casdin Partners amends its previous Form 4 filing to reflect that it received cash instead of shares in BioLife Solutions Inc. following the acquisition of PanThera CryoSolutions, Inc.

Summary

• Casdin Partners Master Fund, L.P. has amended its Form 4 filing related to BioLife Solutions Inc. (BLFS).
• The amendment addresses a previous transaction reported on the original Form 4, which involved the acquisition of PanThera CryoSolutions, Inc. by BioLife Solutions Inc.
• Instead of receiving shares as initially reported, the Reporting Persons ultimately received cash.
• The original Form 4 is being amended to remove the transaction that was previously reported.
• As of the latest filing, Casdin Partners Master Fund, L.P. beneficially owns 8,707,165 shares of Common Stock indirectly.
• The filing also includes information about the relationships of the Reporting Persons to the Issuer, including Director and 10% Owner status.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating a neutral sentiment. The amendment reflects a change in transaction details, but does not inherently suggest positive or negative implications for the company's performance.

Management Comments

• Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to the market.

Stakeholder Impact

• The amendment provides clarity to shareholders regarding the transaction related to the PanThera CryoSolutions acquisition.

Key Dates

Keywords

Form 4, Amendment, Beneficial Ownership, BioLife Solutions Inc, BLFS, Casdin Partners, PanThera CryoSolutions, Acquisition, Shares, Cash